WebKatherine A. High is an American doctor-scientist who is an emeritus professor at the Perelman School of Medicine at the University of Pennsylvania.She was the co-founder, president, and chief scientific officer of Spark Therapeutics and currently serves as President of Therapeutics at AskBio. Her career has focused on pioneering work in the … WebHemophilia. Hemophilia is a disease of the clotting system of the blood and is the most common bleeding disorder in cats and dogs. The clotting mechanism is a cascade of …
VetGen: Veterinary Genetic Services - Canine - List of Services
WebStable and sustained FVIII expression up to 10 years in a large animal model of hemophilia A. Two of 9 dogs experienced a gradual rise in FVIII activity that was 4 times the steady state levels. WebHemophilia A/Factor VIII Deficiency (HEMA) in German Shepherd Dogs. Hemophilia A/Factor VIII Deficiency (HEMA) in Boxers. biopar technology united biopolymer
University of Pennsylvania ScholarlyCommons
WebHemophilia A is a deficiency of coagulation factor VIII, and is the most common inherited clotting disorder in dogs. It can affect most dog … WebNov 12, 2009 · Infusion of cFVIII-BDD in hemophilia A dogs resulted in correction of the disease phenotype with a pharmacokinetic profile similar to clinical experience with hFVIII-BDD. Notably, immune tolerance challenges with cFVIII-BDD in young and adult hemophilia A dogs did not induce the formation of neutralizing or nonneutralizing … WebJan 1, 2004 · We next prepared AAV-1 vectors expressing canine F.IX (cF.IX) and injected these at intramuscular sites in dogs with hemophilia B arising from a missense mutation. 9 At vector doses lower than those used in previous studies with AAV-2, 10 we saw circulating cF.IX levels in the range of 87 ng/mL to 104 ng/mL in the first few weeks after ... bioparc wildlife park